Informative censoring by health plan disenrollment among commercially insured adults

被引:8
|
作者
Butler, Anne M. [1 ,2 ]
Todd, Jonathan V. [3 ]
Sahrmann, John M. [1 ]
Lesko, Catherine R. [4 ]
Brookhart, M. Alan [5 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[3] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[5] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
administrative claims; epidemiologic methods; informative censoring; pharmacoepidemiology; selection bias; INVERSE PROBABILITY; MANAGED CARE; VOLUNTARY DISENROLLMENT; SELECTION BIAS; MEDICAID; PATTERNS; WEIGHTS;
D O I
10.1002/pds.4750
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Health plan disenrollment occurs frequently in commercial insurance claims databases. If individuals who disenroll are different from those who remain enrolled, informative censoring may bias descriptive statistics as well as estimates of causal effect. We explored whether patterns of disenrollment varied by patient or health plan characteristics. Methods: In a large cohort of commercially insured adults (2007-2013), we examined two primary outcomes: (a) within-year disenrollment between January 1 and December 30, which was considered to occur due to patient disenrollment from the health plan, and (b) end-of-year disenrollment on December 31, which was considered to occur due to either patient disenrollment from the health plan or withdrawal of the entire health plan from the commercial insurance database. In yearly cohorts, we identified factors independently associated with disenrollment by using log-binomial regression models to estimate risk ratios (RR) and 95% confidence intervals (CI). Results: Among 2 053 100 unique patient years, the annual proportion of within-year disenrollment remained steady across years (range, 13% to 14%) whereas the annual proportion of end-of-year disenrollment varied widely (range, 8% to 26%). Independent predictors of within-year disenrollment were related to health status, including age, comorbidities, frailty, hospitalization, emergency room visits, use of durable medical equipment, use of preventive care, and use of prescription medications. In contrast, independent predictors of end-of-year disenrollment were related to health plan characteristics including insurance plan type and geographic characteristics. Conclusions: Differential risk of disenrollment suggests that analytic approaches to address selection bias should be considered in studies using commercial insurance databases.
引用
收藏
页码:640 / 648
页数:9
相关论文
共 50 条
  • [21] Changes in Health Care Utilization and Costs among Commercially Insured US Adults with Diabetes during the COVID-19 Pandemic
    Zhou, Xilin
    Lundeen, Elizabeth A.
    Rolka, Deborah B.
    [J]. DIABETES, 2023, 72
  • [22] Social Determinants of Health and High-Cost Utilization Among Commercially Insured Population
    Andreyeva, Elena
    Chi, Winnie
    Zhang, Yongkang
    Kaushal, Rainu
    Haynes, Kevin
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (07): : E199 - E207
  • [23] Public health impact of Rotarix vaccination among commercially insured children in the United States
    Krishnarajah, Girishanthy
    Kageleiry, Andrew
    Korves, Caroline
    Lefebvre, Patrick
    Duh, Mei S.
    [J]. VACCINE, 2017, 35 (37) : 5065 - 5072
  • [24] Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults
    Brito, Juan P.
    Deng, Yihong
    Ross, Joseph S.
    Choi, Nam Hee
    Graham, David J.
    Qiang, Yandong
    Rantou, Elena
    Wang, Zhong
    Zhao, Liang
    Shah, Nilay D.
    Lipska, Kasia J.
    [J]. ENDOCRINE, 2022, 76 (02) : 349 - 358
  • [25] Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17
    Shen, Karen
    Barrette, Eric
    Dafny, Leemore S.
    [J]. HEALTH AFFAIRS, 2020, 39 (06) : 993 - 1001
  • [26] Cost and resource utilization associated with glioblastoma among commercially insured adults in the United States (US).
    Jiang, Shan
    Hill, Kala
    Patel, Dipen
    Waldeck, Adrian Reg
    Botteman, Marc
    Norden, Andrew David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Benzodiazepine Use among Medicare,Commercially Insured, and Veteran Older Adults, 2013-2017
    Maust, Donovan T.
    Kim, H. Myra
    Wiechers, Ilse R.
    Ignacio, Rosalinda V.
    Bohnert, Amy S. B.
    Blow, Frederic C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (01) : 98 - 105
  • [28] Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014
    Kao-Ping Chua
    Rena M. Conti
    [J]. Journal of General Internal Medicine, 2019, 34 : 338 - 340
  • [29] Health related social needs and whole person health: Relationship between unmet social needs, health outcomes, and healthcare spending among commercially insured adults
    Falconi, April M.
    Johnson, Martha
    Chi, Winnie
    Stephenson, Judith J.
    Overhage, J. Marc
    Agrawal, Shantanu
    [J]. PREVENTIVE MEDICINE REPORTS, 2023, 36
  • [30] Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002
    Delate, T
    Simmons, VA
    Motheral, BR
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (04) : 313 - 318